50 employees
Neurotec Pharma is focused on developing new treatments for acute and chronic central nervous system (CNS) diseases.
2006
$4.5M
from 1 investors over 1 rounds
Neurotec Pharma S. L. raised $4.5M on February 19, 2011
Investors: Inveready